RNVA - Rennova Health, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Rennova Health, Inc.

400 South Australian Avenue
8th Floor
West Palm Beach, FL 33401
United States

Full Time Employees94

Key Executives

Mr. Seamus LaganCEO, Pres, Interim CFO & Director587kN/A48
Ms. Victoria Nemerson Esq.Gen. Counsel & Exec. VPN/AN/AN/A
Ms. Karen TaylorDirector of HRN/AN/AN/A
Mr. Sebastien SainsburyCompany Sec. & CEO of Platinum Financial Solutions, LtdN/AN/AN/A
Dr. Bharat Madireddy Ph.D.CEO of Rennova Owned Laboratories and COO of Medytox Diagnostics Inc.N/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Rennova Health, Inc., together with its subsidiaries, provides a suite of healthcare related products and services to healthcare providers in the United States. The company operates in three segments: Laboratory Services, Supportive Software Solutions, and Decision Support and Informatics Operations. It provides toxicology, clinical pharmacogenetics, and esoteric testing services. The company also offers Advantage, a HIPAA compliant software; Clinlab, a Windows-based Web-enabled laboratory information management system; and Medical Mime, a suite of solutions, which include an optimized Electronic health records (EHR) for substance abuse and behavioral health providers, a dictation-based ambulatory EHR for physician practices, and advanced transcription services. In addition, it develops and markets interpretation and decision support solutions that enhance cancer diagnoses and treatment through actionable data analytics and reporting for oncologists and their patients. Rennova Health, Inc. was founded in 2005 and is headquartered in West Palm Beach, Florida.

Corporate Governance

Rennova Health, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.